REAL-WORLD TREATMENT PATTERNS AND PATIENTS CHARACTERISTICS IN MULTIPLE MYELOMA ACROSS EUROPE

被引:0
|
作者
Fernandez, A. [1 ]
Zomas, A. [1 ]
Papakostas, E. [1 ]
Do, T. [1 ]
Russo, M. [2 ]
D'Ambrosio, R. [1 ]
Schneidewind, G. [1 ]
机构
[1] Takeda, EUCAN Med Affairs, CH-8152 Zurich, Switzerland
[2] Takeda, Global Market Access, CH-8152 Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E1263
引用
收藏
页码:517 / 518
页数:2
相关论文
共 50 条
  • [1] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [2] UNDERSTANDING THE REAL-WORLD CLINICAL CHARACTERISTICS OF MULTIPLE MYELOMA PATIENTS IN EUROPE
    Bacon, T.
    Gaudig, M.
    Ito, T.
    Hadfield, A.
    Rider, A.
    HAEMATOLOGICA, 2017, 102 : 529 - 529
  • [3] Real-world treatment patterns, healthcare resource use and disease burden in patients with multiple myeloma in Europe
    Martinez-Lopez, Joaquin
    Bailey, Abigail
    Lambert, Annabel
    Luke, Emily
    Ribbands, Amanda
    Erler-Yates, Nichola
    Valluri, Satish
    Haefliger, Benjamin
    Gay, Francesa
    FUTURE ONCOLOGY, 2023, 19 (31) : 2103 - 2121
  • [4] Real-World Multiple Myeloma Treatment Patterns By Patient Characteristics and Outcomes in the United States
    Richter, Joshua
    Singh, Erin
    Rice, Megan S.
    BLOOD, 2021, 138
  • [5] Characteristics, Treatment Patterns, and Outcomes of Patients with Multiple Myeloma Retreated with Daratumumab in Real-World Clinical Practice in the USA
    Ailawadhi, Sikander
    Larson, Sarah M.
    Ferrante, Shannon
    Rafalko, Nicole
    Gupta-Werner, Niodita
    Harper, Jennifer S.
    Medhekar, Rohan
    Armoon, Marjohn
    Cortoos, Annelore
    Kaila, Shuchita
    Atrash, Shebli
    BLOOD, 2024, 144 : 2381 - 2382
  • [6] Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada
    Jimenez-Zepeda, Victor H.
    Chen, Guanmin
    Shaw, Eileen
    Farris, Megan S.
    Cowling, Tara
    Tay, Jason
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2557 - 2564
  • [7] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    BLOOD, 2018, 132
  • [8] SURVIVAL AND TREATMENT PATTERNS IN PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA (MM) IN A REAL-WORLD SETTING
    Hajek, R.
    Jarkovsky, J.
    Maisnar, V.
    Pour, L.
    Spicka, I.
    Minarik, J.
    Gregora, E.
    Kessler, P.
    Sykora, M.
    Frankova, H.
    Adamova, D.
    Wrobel, M.
    Mikula, P.
    Campioni, M.
    DeCosta, L.
    Treur, M.
    Gonzalez-McQuire, S.
    Bouwmeester, W.
    HAEMATOLOGICA, 2016, 101 : 529 - 529
  • [9] Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe
    Lehne, Moritz
    Kortuem, K. Martin
    Zamagni, Elena
    d'Estrube, Tim
    Shukla, Soham
    Zhuleku, Evi
    Ghiani, Marco
    Hanna, Maya
    Maywald, Ulf
    Wilke, Thomas
    Perera, Sue
    BLOOD, 2022, 140 : 12485 - 12486
  • [10] Patient characteristics and burden in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Gay, Francesca
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S294 - S295